Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

5.8K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.8K
Base Excision Repair01:54

Base Excision Repair

3.6K
3.6K
Next-generation Sequencing03:00

Next-generation Sequencing

88.7K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
88.7K
Homologous Recombination02:31

Homologous Recombination

50.5K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.5K
DNA Damage Can Stall the Cell Cycle02:37

DNA Damage Can Stall the Cell Cycle

2.6K
2.6K
Fixing Double-strand Breaks02:04

Fixing Double-strand Breaks

3.1K
3.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Real-World Outcomes with BCMA- and GPRC5D-Targeting Bispecific Antibodies in Plasma Cell Leukemia.

Blood advances·2026
Same author

Bridging therapy before CAR-T for multiple myeloma: a survey from the CMWP and CTIWP of the EBMT.

Bone marrow transplantation·2026
Same author

Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium.

Blood cancer journal·2026
Same author

Efficacy of stem cell boost (SCB) for chimeric antigen receptor-T cell therapy (CAR-T)-related hematologic toxicity in patients with relapsed/refractory multiple myeloma (RRMM)-real world experience from the US multiple myeloma immunotherapy consortium.

Blood cancer journal·2026
Same author

The impact of extramedullary and paraskeletal plasmacytomas on treatment outcomes in multiple myeloma treated with teclistamab: U.S. Myeloma Immunotherapy Consortium real-world experience.

Blood cancer journal·2025
Same author

Daratumumab plus lenalidomide maintenance in newly diagnosed multiple myeloma after transplant: AURIGA subgroup analyses.

Blood cancer journal·2025
Same journal

Endocrinopathies and growth in a UK cohort of children with transfusion dependent thalassaemia.

British journal of haematology·2026
Same journal

Comparative effectiveness of chimeric antigen receptor (CAR) T-cell therapy versus historical controls in patients with relapse/refractory aggressive B-cell lymphoma: An indirect treatment comparison in the real-world setting.

British journal of haematology·2026
Same journal

Plasma metabolomics profile alterations in the onset and progression of paediatric immune thrombocytopenia.

British journal of haematology·2026
Same journal

Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) induction prior to autologous haematopoietic stem cell transplant/transplantation in newly diagnosed multiple myeloma.

British journal of haematology·2026
Same journal

Immortal time bias limits the conclusion that post-transplant hypomethylating agent maintenance improves outcomes in myelodysplastic syndromes.

British journal of haematology·2026
Same journal

Author response to Zhang and Chen.

British journal of haematology·2026
查看所有相关文章

相关实验视频

Updated: Jun 29, 2025

A Deep-sequencing-assisted, Spontaneous Suppressor Screen in the Fission Yeast Schizosaccharomyces pombe
07:55

A Deep-sequencing-assisted, Spontaneous Suppressor Screen in the Fission Yeast Schizosaccharomyces pombe

Published on: March 7, 2019

8.0K

序列没有救援.

Douglas W Sborov1, Gliceida Galarza Fortuna1, Patrick J Hayden2

  • 1Huntsman Cancer Institute at the University of Utah, Salt Lake City, Utah, USA.

British journal of haematology
|April 2, 2024
PubMed
概括
此摘要是机器生成的。

针对多发性骨髓瘤的BCMA向CAR-T疗法后的救援治疗非常重要,因为这种疾病仍然无法治愈. 这项研究分析了在CAR-T疗法后需要进一步治疗的患者的结果,强调了需要有效的后续选择的需要.

关键词:
T细胞重定向双特异性抗体.仿制抗原受体 (CAR) T细胞疗法多发性骨髓瘤是多发性骨髓瘤的一种.蛋白质酶体抑制剂 蛋白质酶体抑制剂

更多相关视频

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER
14:06

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Published on: June 23, 2012

15.2K
Optimization for Sequencing and Analysis of Degraded FFPE-RNA Samples
07:30

Optimization for Sequencing and Analysis of Degraded FFPE-RNA Samples

Published on: June 8, 2020

12.0K

相关实验视频

Last Updated: Jun 29, 2025

A Deep-sequencing-assisted, Spontaneous Suppressor Screen in the Fission Yeast Schizosaccharomyces pombe
07:55

A Deep-sequencing-assisted, Spontaneous Suppressor Screen in the Fission Yeast Schizosaccharomyces pombe

Published on: March 7, 2019

8.0K
Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER
14:06

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Published on: June 23, 2012

15.2K
Optimization for Sequencing and Analysis of Degraded FFPE-RNA Samples
07:30

Optimization for Sequencing and Analysis of Degraded FFPE-RNA Samples

Published on: June 8, 2020

12.0K

科学领域:

  • 血液学 血液学 血液学
  • 在瘤学瘤学.
  • 免疫治疗是一种免疫疗法.

背景情况:

  • 针对B细胞成熟抗原 (BCMA) 的化学抗原受体T细胞 (CAR-T) 疗法已经改变了复发性/耐药性多发性骨髓瘤 (RRMM) 治疗.
  • 尽管最初的疗效很好,但由于疾病无法治愈,大多数患者最终需要进行后续治疗.

研究的目的:

  • 评估在接受BCMA特异性CAR-T治疗的多发性骨髓瘤患者中救援治疗的结果.
  • 在RRMM中CAR-T失败后确定最佳的下一线治疗策略.

主要方法:

  • 对LEGEND-2研究数据的回顾性分析.
  • 对接受BCMA CAR-T治疗后救援疗法的患者结局的检查.

主要成果:

  • 大多数接受BCMA特异性CAR-T治疗RRMM的患者最终需要救援治疗.
  • 在CAR-T治疗后,各种救援方案的有效性和安全性需要进一步研究.

结论:

  • 随后的治疗策略对于在BCMA向的CAR-T治疗后管理多发性骨髓瘤至关重要.
  • 需要进一步的研究来确定最佳的救援治疗途径,用于RRMM后CAR-T.患者.